We are live on ! Find out more
CUAMC

China Universal Asset Management Company Portfolio holdings

AUM $1.67B
1-Year Est. Return 89%
This Fund
S&P 500
This Quarter Est. Return
+18.11%
1 Year Est. Return
+89%
3 Year Est. Return
+264.17%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$514M
AUM Growth
+$169M
Cap. Flow
+$103M
Cap. Flow %
19.96%
Top 10 Hldgs %
26.88%
Holding
503
New
57
Increased
239
Reduced
90
Closed
78

Top Buys

Rank Stock Value
1
VRTX icon
Vertex Pharmaceuticals
VRTX
+$6.25M
2
GILD icon
Gilead Sciences
GILD
+$6.13M
3
REGN icon
Regeneron Pharmaceuticals
REGN
+$6.05M
4
AMGN icon
Amgen
AMGN
+$5.9M
5
ADBE icon
Adobe
ADBE
+$5.02M

Top Sells

Rank Stock Value
1
NVDA icon
NVIDIA
NVDA
+$4.85M
2
ADI icon
Analog Devices
ADI
+$3.37M
3
AMZN icon
Amazon
AMZN
+$3.21M
4
LULU icon
lululemon athletica
LULU
+$2.87M
5
ORCL icon
Oracle
ORCL
+$1.91M

Sector Composition

Rank Sector Weight
1 Technology 34.39%
2 Healthcare 30.05%
3 Consumer Discretionary 17.55%
4 Communication Services 6.11%
5 Consumer Staples 4.61%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
YUM icon
176
Yum! Brands
YUM
$41B
$299K 0.06%
2,285
– –
VRNA
177
DELISTED
Verona Pharma
VRNA
$296K 0.06%
14,878
-40,806
-73% -$603K
CTLT
178
DELISTED
CATALENT, INC.
CTLT
$283K 0.06%
6,301
-38,319
-86% -$1.55M
HON icon
179
Honeywell
HON
$74.6B
$275K 0.05%
1,392
-1,233
-47% -$222K
CRNX icon
180
Crinetics Pharmaceuticals
CRNX
$8.96B
$275K 0.05%
7,721
+6,318
+450% +$194K
AMAT icon
181
Applied Materials
AMAT
$435B
$268K 0.05%
1,652
-1,465
-47% -$215K
IMCR icon
182
Immunocore
IMCR
$1.77B
$266K 0.05%
3,900
+3,064
+367% +$159K
IDYA icon
183
IDEAYA Biosciences
IDYA
$3.56B
$265K 0.05%
7,453
+5,979
+406% +$178K
SWTX
184
DELISTED
SpringWorks Therapeutics
SWTX
$264K 0.05%
7,237
+5,625
+349% +$147K
BEAM icon
185
Beam Therapeutics
BEAM
$2.76B
$263K 0.05%
9,667
+7,395
+325% +$184K
ARVN icon
186
Arvinas
ARVN
$580M
$262K 0.05%
6,370
+4,996
+364% +$117K
YMM icon
187
Full Truck Alliance
YMM
$9.62B
$260K 0.05%
37,130
-125,700
-77% -$886K
TWST icon
188
Twist Bioscience
TWST
$7.85B
$246K 0.05%
6,674
+5,204
+354% +$120K
IOVA icon
189
Iovance Biotherapeutics
IOVA
$3.05B
$241K 0.05%
29,602
+23,246
+366% +$122K
PTCT icon
190
PTC Therapeutics
PTCT
$6.06B
$241K 0.05%
8,727
+6,786
+350% +$155K
RXRX icon
191
Recursion Pharmaceuticals
RXRX
$1.76B
$238K 0.05%
24,091
+18,854
+360% +$134K
VFC icon
192
VF Corp
VFC
$5.73B
$234K 0.05%
+12,460
New +$214K
VCYT icon
193
Veracyte
VCYT
$3.59B
$232K 0.05%
8,448
+6,586
+354% +$159K
SDGR icon
194
Schrodinger
SDGR
$1.39B
$229K 0.04%
6,410
-16,092
-72% -$467K
PRTA icon
195
Prothena Corp
PRTA
$475M
$225K 0.04%
6,203
+4,828
+351% +$186K
CHPT icon
196
ChargePoint
CHPT
$166M
$222K 0.04%
4,750
– –
HRMY icon
197
Harmony Biosciences
HRMY
$2.32B
$219K 0.04%
6,777
+5,244
+342% +$146K
LEVI icon
198
Levi Strauss
LEVI
$8.64B
$215K 0.04%
+12,970
New +$192K
SMMT icon
199
Summit Therapeutics
SMMT
$12B
$212K 0.04%
81,071
+63,168
+353% +$130K
DVAX
200
DELISTED
Dynavax Technologies
DVAX
$209K 0.04%
+14,956
New +$208K
6 7
8
9 10

Similar funds

HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
JPM
JANA Partners Management New York $1.67B AUM 1.66% 1-Year Est. Return
CPO
Cerity Partners OCIO New York $1.67B AUM 13.22% 1-Year Est. Return
LCI
L1 Capital International Sydney NSW 2000, Australia $1.68B AUM 9.83% 1-Year Est. Return
GWM
GDS Wealth Management Flower Mound, Texas $1.66B AUM 18.11% 1-Year Est. Return
JIP
Jaffetilchin Investment Partners Tampa, Florida $1.68B AUM 22.81% 1-Year Est. Return
RMC
Ribbit Management Company Palo Alto, California $1.68B AUM 40.61% 1-Year Est. Return
GACM
Global Alpha Capital Management Montreal, Quebec, Canada $1.66B AUM 27.98% 1-Year Est. Return

China Universal Asset Management Company's Q4 2023 Portfolio in Review

As of Q4 2023, China Universal Asset Management Company held 503 positions worth $514M, up 49% from $345M the previous quarter. Its ten largest holdings account for 27% of the portfolio.

China Universal Asset Management Company deployed $103M of net new capital in Q4 2023, opening 57 new positions and adding to 239 existing holdings. Its largest new stake was GSK: 54,345 shares worth $2.03M.

By sector, the portfolio is most concentrated in Technology at 34% of assets, down from 38% a quarter earlier, followed by Healthcare and Consumer Discretionary.

On the sell side, the largest reduction was NVIDIA, an estimated $4.85M trimmed.

  • China Universal Asset Management Company's largest Q4 2023 buy was GSK: 54,345 shares worth $2.03M.
  • China Universal Asset Management Company added most to Vertex Pharmaceuticals in Q4 2023, an estimated $6.25M increase.
  • China Universal Asset Management Company's biggest Q4 2023 reduction was NVIDIA, cutting an estimated $4.85M.
  • China Universal Asset Management Company fully exited Oracle in Q4 2023, selling an estimated $1.91M.
  • China Universal Asset Management Company's ten largest holdings make up 27% of its $514M portfolio in Q4 2023.
  • China Universal Asset Management Company opened 57 new positions and closed 78 in Q4 2023.
  • China Universal Asset Management Company's portfolio value rose 49% quarter-over-quarter to $514M.

Based on China Universal Asset Management Company's 13F filing for Q4 2023, filed 24 Jan 2024.